Brain & Nervous System Health Center
Distal Myopathy
Important
It is possible that the main title of the report Distal Myopathy is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Synonyms
- Distal Muscular Dystrophy
Disorder Subdivisions
- Distal Myopathy with Rimmed Vacuoles (DMRV)
- Distal Myopathy with Vocal Cord and Pharyngeal Signs
- Distal Myopathy 3 (MPD3)
- Inclusion Body Myopathy Type 2 (IBM2)
- Laing Distal Myopathy
- Laing Early-Onset Distal Myopathy
- Miyoshi Myopathy
- Nonaka Myopathy
- Tibial Distal Myopathy
- Udd Distal Myopathy
- Welander Distal Myopathy
General Discussion
Distal myopathy (or distal muscular dystrophy) is a general term for a group of rare progressive genetic disorders characterized by wasting (atrophy) and weakness of the voluntary distal muscles. The distal muscles are those farther from the center of the body and include the muscles of the lower arms and legs and the hands and feet. Conversely, the proximal muscles are the muscles closest to the center of the body such as the muscles of the shoulder, pelvis, and upper arms and legs. Although age of onset can occur anytime from infancy to adulthood, most forms develop later in life and are slowly progressive. Inheritance is autosomal dominant or recessive.
The distal myopathies belong to a larger group of disorders known as the muscular dystrophies. The muscular dystrophies are characterized by weakness and degeneration of various voluntary muscles of the body. Approximately 30 different disorders make up the muscular dystrophies. The disorders affect different muscles and have different ages of onset, severity and inheritance patterns.
Resources
March of Dimes Birth Defects Foundation
1275 Mamaroneck Avenue
White Plains, NY 10605
Tel: (914)428-7100
Fax: (914)997-4763
Tel: (888)663-4637
Email: Askus@marchofdimes.com
Internet: http://www.marchofdimes.com
Muscular Dystrophy Association
3300 E. Sunrise Dr
Tucson, AZ 85718
USA
Tel: (520)529-2000
Fax: (520)529-5300
Tel: (800)344-4863
Email: mda@mdausa.org
Internet: http://www.mdausa.org
Muscular Dystrophy Canada
900-2345 Yonge Street
Toronto
Ontario, Intl M4P 2E5
Canada
Tel: 416-488-0030
Fax: 416-488-7523
Tel: (866)-MUSCLE-8
Email: info@muscle.ca
Internet: http://www.muscle.ca
Muscular Dystrophy Campaign
7-11 Prescott Place
London, SW4 6BS
United Kingdom
Email: info@muscular-dystrophy.org
Internet: http://www.muscular-dystrophy.org
National Institute of Neurological Disorders and Stroke (NINDS)
31 Center Drive
8A07
Bethesda, MD 20892-2540
Tel: (301)496-5751
Fax: (301)402-2186
Tel: (800)352-9424
Email: braininfo@ninds.nih.gov
Internet: http://www.ninds.nih.gov/
Muscular Dystrophy Association of New Zealand, Inc.
PO Box 23-047
Papatoetoe
Auckland,
New Zealand
Tel: 09 2787216
Fax: 09 2777540
Tel: 0800800337
Email: nzmda@nzmda.ak.planet.gen.nz
Muscular Dystrophy Association (Australia)
GPO Box 9932
Melbourne, Intl 3001
Australia
Tel: 61 3 9320 9555
Fax: 61 3 9320 9595
Tel: 1 800 656 632
Email: info@mda.org.au
Internet: http://www.mda.org.au
European Alliance of Neuromuscular Disorders Associations
MDG Malta 4,
Gzira Road
Gzira, Intl GAR 04
Malta
Tel: 00356 21 346688
Fax: 00356 21 318024
Email: eamda@hotmail.com
Internet: http://www.eamda.net
Muscular Dystrophy Ireland
71/72 North Brunswich Street
Dublin 7, Intl
Ireland
Tel: 353 1 8721501
Fax: 353 1 8724482
Email: info@mdi.ie
Internet: http://www.mdi.ie/
Jain Foundation Inc.
2889 152nd Ave NE
Unit C
Redmond, WA 98052
Tel: (425)882-1492
Fax: (240)282-0510
Email: plavimittal@jain-foundation.org
Internet: http://www.jain-foundation.org
For a Complete Report:
This is an abstract of a report from the National Organization for Rare Disorders, Inc. ® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 4/6/2007
Copyright 2007 National Organization for Rare Disorders, Inc.
WebMD Medical Reference from the National Organization of Rare Disorders
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information
Brain & Nervous System Health Center
Many people experience dizzy spells, but how much is too much? Learn when dizzy equals danger.
